This is the largest worldwide action aimed at screening for malignant skin neoplasms, surpassing the initiatives of the European community. 2 In addition to actions associated with population health ...

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...